Immunosenescence and Inflammation in Chronic Obstructive Pulmonary Disease: A Systematic Review
-
Published:2024-06-13
Issue:12
Volume:13
Page:3449
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Ramos Jesus Fabíola12, Correia Passos Fabine2ORCID, Miranda Lopes Falcão Michelle3ORCID, Vincenzo Sarno Filho Marcelo4, Neves da Silva Ingrid Lorena2ORCID, Santiago Moraes Anna Clara2ORCID, Lima Costa Neves Margarida Célia4ORCID, Baccan Gyselle Chrystina2ORCID
Affiliation:
1. Maternidade Climério de Oliveira (MCO/EBSERH), Universidade Federal da Bahia, Salvador 40055-150, Bahia, Brazil 2. Departamento de Bioquímica e Biofísica, Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador 40110-110, Bahia, Brazil 3. Departamento de Saúde, Universidade Estadual de Feira de Santana, Avenida Transnordestina, s/n—Novo Horizonte, Feira de Santana 44036-900, Bahia, Brazil 4. Unidade do Sistema Respiratório, Ambulatório Professor Francisco Magalhães Neto-Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador 40110-200, Bahia, Brazil
Abstract
Background/Objectives: Chronic Obstructive Pulmonary Disease (COPD) is a disease of premature aging, characterized by airflow limitations in the lungs and systemic chronic inflammation. This systematic review aimed to provide a systematic overview of immunosenescence and inflammation in Chronic Obstructive Pulmonary Disease (COPD). Methods: The PubMed, Science Direct, Scopus, Cochrane Library, and Web of Science databases were searched for studies on markers of immunosenescence. Observational studies comparing patients with COPD to individuals without disease were evaluated, considering the following markers: inflammation and senescence in COPD, naïve, memory, and CD28null T cells, and telomere length in leukocytes. Results: A total of 15 studies were included, eight of which were rated as high quality. IL-6 production, telomere shortening, and the higher frequencies of CD28null T cells were more prominent findings in the COPD studies analyzed. Despite lung function severity being commonly investigated in the included studies, the importance of this clinical marker to immunosenescence remains inconclusive. Conclusions: The findings of this systematic review confirmed the presence of accelerated immunosenescence, in addition to systemic inflammation, in stable COPD patients. Further studies are necessary to more comprehensively evaluate the impact of immunosenescence on lung function in COPD.
Funder
National Council for Scientific and Technological Development-Brazil Bahia State Research Support Foundation
Reference77 articles.
1. Chronic Obstructive Pulmonary Disease;Flenley;Disease-a-Month,1988 2. Szalontai, K., Gémes, N., Furák, J., Varga, T., Neuperger, P., Balog, J.Á., Puskás, L.G., and Szebeni, G.J. (2021). Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. J. Clin. Med., 10. 3. Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene;Ragland;Am. J. Respir. Crit. Care Med.,2019 4. Karametos, I., Tsiboli, P., Togousidis, I., Hatzoglou, C., Giamouzis, G., and Gourgoulianis, K. (2019). Chronic Obstructive Pulmonary Disease as a Main Factor of Premature Aging. Int. J. Environ. Res. Public Health, 16. 5. Global, Regional, and National Prevalence of, and Risk Factors for, Chronic Obstructive Pulmonary Disease (COPD) in 2019: A Systematic Review and Modelling Analysis;Adeloye;Lancet Respir. Med.,2022
|
|